Recombinant Sars-2 Spike Protein

Lab Reagents

Human IgG antibody Laboratories manufactures the recombinant sars-2 spike protein reagents distributed by Genprice. The Recombinant Sars-2 Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Recombinant. Other Recombinant products are available in stock. Specificity: Recombinant Category: Sars-2 Group: Spike Protein

Spike Protein information

Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD)

P1533-50 50 µg
EUR 591

SARS-CoV-2(COVID-19) Spike Recombinant Protein

10-411 0.1 mg
EUR 595.25
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

SARS-CoV-2 (COVID-19) Spike Recombinant Protein

11-073 0.1 mg
EUR 579.5
Description: May down-regulate host tetherin (BST2) by lysosomal degradation, thereby counteracting its antiviral activity.

SARS-CoV-2 (COVID-19) Spike Recombinant Protein

20-233 0.1 mg
EUR 605.75
Description: SARS-CoV-2 (COVID-19) Spike Recombinant Protein

Recombinant 2019-nCoV coronavirus Spike protein S1 subunit receptor binding domain

Spike-19V 100ug
EUR 792
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit receptor binding domain (RBD) was fused to Mouse IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.

Recombinant 2019-nCoV coronavirus Spike protein, S1 subunit, expressed in Baculovirus-Insect cells

Spike-195V 100ug
EUR 1610
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant 2019-nCoV coronavirus Spike protein, S2 ECD, expressed in Baculovirus-Insect cells

Spike-197V 100ug
EUR 1610
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein (S2 ECD) was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant Coronavirus Spike Protein (SARS-CoV-2; His tag)

P1528-10 10 µg
EUR 196

Recombinant Coronavirus Spike Protein (SARS-CoV-2; His tag)

P1528-50 50 µg
EUR 591

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)

P1540-10 10 µg
EUR 176

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)

P1540-50 50 µg
EUR 682

Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag)

P1541-10 10 µg
EUR 176

Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag)

P1541-50 50 µg
EUR 682

SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein

10-008 0.1 mg
EUR 595.25
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus.

SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein

10-015 0.1 mg
EUR 595.25
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus.

SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein

10-100 0.1 mg
EUR 542.75
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity.

SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein

10-107 0.1 mg
EUR 542.75
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity.